SLC5A2 and Cognitive impairment: Dapagliflozin (DGF), a SGLT2 inhibitor, has been reported to have beneficial effects on cognitive impairment in a rat model of scopolamine-induced memory impairment via its acetylcholinesterase inhibiting activity, which is an additional property of SGLT inhibitors (Rizvi et al.2014 and Arafa et al.2017).